These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 581645)

  • 41. D-lysergic acid diethylamide (LSD)--effect on biogenic amines excretion in man.
    Messiha FS; Grof S
    Biochem Pharmacol; 1973 Sep; 22(18):2352-4. PubMed ID: 4733686
    [No Abstract]   [Full Text] [Related]  

  • 42. Measurements of monoamine synthesis and turnover with special reference to 5-hydroxytryptamine.
    Carlsson A
    Adv Biochem Psychopharmacol; 1974; 10():75-81. PubMed ID: 4152552
    [No Abstract]   [Full Text] [Related]  

  • 43. [The modification by their antagonists of the effects of serotonin and noradrenaline on a conditioned escape reaction in the rat].
    Matthies H; Schmidt J; Krüger H; Horenburg R
    Acta Biol Med Ger; 1971; 26(2):347-53. PubMed ID: 4401185
    [No Abstract]   [Full Text] [Related]  

  • 44. Changes in brain levels of NE and 5-HT are not responsible for attenuation of audiogenic seizures by spinal cordotomy.
    Willott JF; Lints CE; Nenja LH
    Pharmacol Biochem Behav; 1979 Jun; 10(6):957-8. PubMed ID: 289980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Function of monaminergic systems and epilepsy].
    Gusel' VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(6):924-31. PubMed ID: 899502
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacological studies on isolation-induced aggressiveness in mice in relation to biogenic amines.
    Roliński Z
    Pol J Pharmacol Pharm; 1975; 27(1):37-44. PubMed ID: 1167693
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of lysergide and nimergoline on glucose metabolism investigated on the dog brain isolated in situ.
    Benzi G; De Bernardi M; Manzo L; Ferrara A; Panceri P; Arrigoni E; Berté F
    J Pharm Sci; 1972 Mar; 61(3):348-52. PubMed ID: 5013366
    [No Abstract]   [Full Text] [Related]  

  • 48. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
    Hoffmann IS; Talmaciu RK; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ontogeny of brain catecholamine turnover and susceptibility to audiogenic seizures in DBA/2J mice.
    Shaywitz BA; Yager RD; Gordon JW
    Dev Psychobiol; 1978 May; 11(3):243-50. PubMed ID: 658604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures.
    Chapman AG; Croucher MJ; Meldrum BS
    Arzneimittelforschung; 1984; 34(10):1261-4. PubMed ID: 6542784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Catechol-O-methyl transferase and monoamine oxidase activities in brains of mice susceptible and resistant to audiogenic seizures.
    Schlesinger K; Harkins J; Deckard BS; Paden C
    J Neurobiol; 1975 Nov; 6(6):587-96. PubMed ID: 1185192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of various serotoninergically induced manipulations on audiogenic seizures in magnesium-deficient mice.
    Bac P; Pages N; Herrenknecht C; Dewulf C; Binet P; Durlach J
    Magnes Res; 1994 Jun; 7(2):107-15. PubMed ID: 7999524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacology of synaptic monoamine transmission.
    Carlsson A
    Prog Brain Res; 1969; 31():53-9. PubMed ID: 4310660
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
    Andén NE
    Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of the ergot alkaloid elymoclavine on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VD; Konstantinova E
    Arch Int Pharmacodyn Ther; 1986 May; 281(1):22-34. PubMed ID: 2428322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Psychopharmacological study of some derivatives analogous with lysergic acid].
    Sivadjian J
    C R Acad Hebd Seances Acad Sci D; 1970 May; 270(20):2499-501. PubMed ID: 4987582
    [No Abstract]   [Full Text] [Related]  

  • 57. An investigation on the behavioral and hypothermic effects of yohimbine: interaction with drugs affecting central and peripheral monoamines.
    Papeschi R
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):61-80. PubMed ID: 4276928
    [No Abstract]   [Full Text] [Related]  

  • 58. Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour.
    Green AR; Deakin JF
    Nature; 1980 May; 285(5762):232-3. PubMed ID: 7374776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Central dopaminergic and noradrenergic components of bromocryptine-induced locomotor activity in mice [proceedings].
    Dolphin AC; Jenner P; Marsden CD; Sawaya MC
    Br J Pharmacol; 1977 Mar; 59(3):467P. PubMed ID: 576587
    [No Abstract]   [Full Text] [Related]  

  • 60. Action of lysergide, ephedrine, and nimergoline on brain metabolizing activity.
    Benzi G; Manzo L; De Bernardi M; Ferrara A; Sanguinetti L; Arrigoni E; Berté F
    J Pharm Sci; 1971 Sep; 60(9):1320-4. PubMed ID: 5567577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.